新型冠状病毒S蛋白B细胞表位的预测与分析

doi:10.3969/j.issn.2095-9400.2020.03.001

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1723 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：分析新型冠状病毒（SARS-CoV-2）S刺突蛋白的二级结构并预测其可能的B细胞表位。方法：基于SARS-CoV-2 S蛋白氨基酸序列，分别采用SOPMA、GOR方法预测S蛋白的二级结构，并结合其跨膜区、亲水性、表面可及性和抗原性参数等综合分析，预测SARS-CoV-2 S蛋白可能的B细胞表位。结果：对SARS-CoV-2 S蛋白二级结构的预测表明，其二级结构中柔性区域以无规卷曲为主，少见转角。多种参数综合分析推测，其可能的优势B细胞表位位于354～360、437～445、454～471、527～537、567～582、678～685、772～779和806～818位氨基酸。结论：采用多参数预测SARS-CoV-2 S蛋白的B细胞表位，为深入研究S蛋白的功能奠定基础。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	朱珊丽
	丁宁
	项丹
	董海艳
	薛向阳
	张丽芳

关键词 ：新型冠状病毒, S蛋白, B细胞表位, 预测

Abstract：Objective: To predict the secondary structure and B-cell epitopes of S protein of SARS-CoV-2. Methods: The amino acids of SARS-CoV-2 S protein were selected, and the secondary structure was predicted by SOPMA and GOR methods. A combined comprehensive analysis of transmembrane domain, hydrophilicity profile, surface probability and antigenicity index was further made to predict B-cell epitopes of S protein. Results: Prediction of the secondary structure of SARS-CoV-2 S protein indicated that random coils were the main structural type of the flexible region in secondary structure. The predominant B-cell epitopes were probably in the regions of 354-360, 437-445, 454-471, 527-537, 567-582, 678-685, 772-779 and 806-818 amino acids. Conclusion: The B-cell epitope of SARS-CoV-2 S protein can be predicted by multi parameters, which lays foundations for further study of the function of S protein.

Key words： SARS-CoV-2 S protein B-cell epitope prediction

作者简介: 朱珊丽（1979-），女，河南郑州人，副教授。

链接本文:

https://xb.wmu.edu.cn/CN/10.3969/j.issn.2095-9400.2020.03.001 或 https://xb.wmu.edu.cn/CN/Y2020/V50/I3/173

[1] 闻玉梅. 冠状病毒的致病性及防控[J]. 微生物与感染, 2020, 15(1): 2-5.
[2] HULSWIT R J, DE HAAN C A, BOSCH B J. Coronavirus spike protein and tropism changes[J]. Adv Virus Res, 2016, 96: 29-57.
[3] XU X, CHEN P, WANG J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. Sci China Life Sci, 2020, 63(3): 457-460.
[4] KYTE J, DOOLITTLE R F. A simple method for displaying the hydropathic character of a protein[J]. J Mol Biol, 1982, 157(1): 105-132.
[5] EMINI E A, HUGHES J V, PERLOW D S, et al. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide[J]. J Virol, 1985, 55(3): 836-839.
[6] JAMESON B A, WOLF H. The antigenic index: a novel algorithm for predicting antigenic determinants[J]. Comput Appl Biosci, 1988, 4(1): 181-186.
[7] 吴玉章, 朱锡华. 一种病毒蛋白B细胞表位预测方法的建立[J]. 科学通报, 1994(24): 2275-2279.
[8] DU L, HE Y, ZHOU Y, et al. The spike protein of SARS-CoV-a target for vaccine and therapeutic development[J]. Nat Rev Microbiol, 2009, 7(3): 226-236.
[9] LIU L, WEI Q, LIN Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection[J]. JCI Insight, 2019, 4(4): 123158.
[10] CZUB M, WEINGARTL H, CZUB S, et al. Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets[J]. Vaccine, 2005, 23(17-18): 2273-2279.
[11] WEINGARTL H, CZUB M, CZUB S, et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets[J]. J Virol, 2004, 78(22): 12672-12676.
[12] YIP M S, LEUNG H L, LI P H, et al. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS[J]. Hong Kong Med J, 2016, 22(3 Suppl 4): 25-31.
[13] WALLS A C, XIONG X, PARK Y J, et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion[J]. Cell, 2019, 176(5): 1026-1039.
[14] DU L, YANG Y, ZHOU Y, et al. MERS-CoV spike protein: a key target for antivirals[J]. Expert Opin Ther Targets, 2017, 21(2): 131-143.
[15] ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270-273.
[16] WALLS A C, TORTORICI M A, SNIJDER J, et al. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion[J]. Proc Natl Acad Sci U S A, 2017, 114(42): 11157-11162.
[17] HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020. DOI: 10.1016/j.cell.2020.02.052.
[18] BELOUZARD S, CHU V C, WHITTAKER G R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites[J]. Proc Natl Acad Sci U S A, 2009, 106(14): 5871-5876.
[19] WRAPP D, WANG N, CORBETT K S, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conforma-tion[J]. Science, 2020, 367(6483): 1260-1263.